Alembic Pharmaceuticals LimitedShare price targets & analyst calls
₹808.2+4.55 (+0.57%)
As of 4 Sept 2026
Analysts lean BUY·all 3 long-term calls are BUY·consensus 1Y target ₹1,093.67 (35.3% above CMP)
₹1,093.67
35.3% above CMP
₹1,013 – ₹1,136
3 active 1Y targets
3 open
3 BUY · 0 SELL (all horizons)
N/A
6 of 10 closed calls needed
Watch APLLTD for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (9) · loading…
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 8 mo left
AI1+·1−+3.1% P&L+25.3% upside left
₹808.2
CMP
Entry*
₹784.1
Target
₹1,013
BCBOB Capital Markets· via Institutional / Brokerage Research16w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 2 mo left
AI1+·1−-15.9% P&L+40.1% upside left
₹808.2
CMP
Entry*
₹960.7
Target
₹1,132
DCDeven Choksey, DRChoksey· via Institutional / Brokerage Research43w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 2 mo left
AI1+·1−-15.9% P&L+40.6% upside left
₹808.2
CMP
Entry*
₹960.7
Target
₹1,136
BCBOB Capital Markets· via Institutional / Brokerage Research43w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+15.07% realised0.0% upside left
Entry*
₹896.85
Target
₹1,032
hit 19 May 2025, 12:00 am
BCBOB Capital Markets· via Institutional / Brokerage Research69w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.11% realised0.0% upside left
Entry*
₹845.15
Target
₹1,032
hit 19 May 2025, 12:00 am
BCBOB Capital Markets· via Institutional / Brokerage Research81w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI6+·1−-13.71% realisedNA upside left
₹818.2
At expiry
Entry*
₹948.25
Target
₹1,101
expired 6 Aug 2026, 3:30 pm
BCBOB Capital Markets· via Institutional / Brokerage Research56w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-14.63% realisedNA upside left
₹921.95
At expiry
Entry*
₹1,079.9
Target
₹1,412
expired 7 Nov 2025, 3:30 pm
BCBOB Capital Markets· via Institutional / Brokerage Research95w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI4+·1−+4.87% realised0.0% upside left
SL
₹791
Entry*
₹805.75
Target
₹845
hit 7 Aug 2026, 10:00 am
SSShivangi Sarda, Motilal Oswal· via CNBC Awaaz.4w ago
BUYAPLLTDAlembic PharmaceuticalsHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-2.61% realisedNA upside left
SL
₹774
Entry*
₹794.75
Target
₹840
hit 11 May 2026, 9:15 am
MJManas Jaiswal· via CNBC Awaaz.17w ago